Navigation Links
Boston Scientific Announces First Quarter Special Items
Date:4/15/2009

NATICK, Mass., April 15 /PRNewswire-FirstCall/ -- Boston Scientific (NYSE: BSX) today announced special items that will reduce its GAAP earnings for the first quarter. The Company plans to release its first quarter financial results on April 20.

As the Company disclosed last month, the Court of Appeals for the Federal Circuit upheld the District Court's decision that Johnson & Johnson's (J&J) Bx Velocity(R) and Cypher(R) Stent Systems infringe Boston Scientific's patent and that the patent is valid. The Appeals Court reversed the District Court with respect to J&J's infringement claims against the TAXUS(R) Liberte(R) Stent and instructed the District Court to dismiss those claims with prejudice. The Company expects to receive a favorable financial award based on the Appeals Court's ruling, but in accordance with accounting regulations the Company will wait until payment is assured before recording any related gain.

In addition, the Court of Appeals affirmed the District Court's decision that Boston Scientific's Express(R), TAXUS(R) Express(R) and Liberte(R) Stents infringe one J&J patent and that the patent is valid. The Court also affirmed that Boston Scientific's Liberte Stent infringes a second J&J patent and that the patent is valid. The Company will record an accrual of $237 million ($197 million after-tax) in the first quarter for its estimated exposure on this ruling, in accordance with accounting regulations. This amount represents an estimate of the low end of the range of potential outcomes related to this matter. The range is subject to substantial estimation, including attempting to determine the possible future findings of a jury. As such, the high end of the range cannot be reasonably estimated at this time.

A damages trial on the above infringements has not been scheduled
'/>"/>

SOURCE Boston Scientific
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Boston Scientific Launches New Coronary Imaging Catheter
2. Moodys Raises Boston Scientifics Rating Outlook to Stable
3. BG Medicine Signs Collaborative Research Agreement with the National Heart, Lung and Blood Institute (NHLBI), and Boston University
4. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 29th Annual Cowen and Company Healthcare Conference in Boston
5. Boston LASIK Eye Surgery Expert Dr. Peter Rapoza Joins Select Group of Doctors in Trusted LASIK Surgeons Directory
6. Boston Scientific Resolves Outstanding Litigation Matter, Finalizes Goodwill Impairment Charge
7. Boston Scientific Announces Japanese Approval for TAXUS(R) Liberte(R) Drug-Eluting Stent System
8. Biotechnology Veteran Michael Webb Joins Boston-based Investment Bank as Senior Advisor
9. Boston Scientific Acquires Labcoat Limited
10. FDA Approves Boston Scientifics Express(R) SD Renal Stent System
11. Kendle to Present at the 2008 Raymond James Boston Fall Investors Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., SEATTLE,Nov.24/PRNewswire-FirstCall/--CellThe...llpresentatthe21stAnnualPiperJaffrayHealthCareConf...heNewYorkPalaceHotel. ,, CTIwillpresentonTuesda...r).AliveaudiowebcastofCTI,spresentationwillbeavail...ailableforreplayafterwards. , ,PiperJaffrayHealth...
(Date:11/23/2009)...HAMPAIGN, Ill. You can think of it as origami ve...sity of Illinois have developed a technique for fa...licon structures from thin films by coupling photo...apillary interactions. , The films, only a few mi...not possible with thicker pieces of the same mater...
(Date:11/23/2009)...raphene consists of a two-dimensional carbon layer...onal lattice, resembling a honeycomb. Carbon nanot...iles of graphene sheets form graphite. Graphene bo...emely tear-resistant, an excellent thermal conduct...rittleness and ductility. In addition, graphene is...
(Date:11/23/2009)..., MISSISSAUGA,ON,Nov.23/PRNewswire-FirstCall/-Y...cesproductdevelopmentcompanythatidentifiesandadvan...ctsatvariousstagesofdevelopment,todayreportedthatC...rialevaluatingCYT387,apotent,orally-administeredJA...nicinRochester,Minnesota.AproposaltomergeCytopiain...
Breaking Biology Technology:Water droplets direct self-assembly process in thin-film materials 2Polymer with honeycomb structure 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4
...ring of outstanding convertible debentures of Vict...t , , QUEBEC, April 30 /PRNewswire-FirstCall/ - V...d Otto Bock HealthCare GmbH ("Otto Bock") announce...ership agreement to establish a joint venture to d...developed by Victhom,s Neurobionix division. , The...
... April 30 /PRNewswire-Asia-FirstCall/ -- China-Bio... Company"), a leading Chinese firm,specializing in... and,distribution of probiotics products ( http://... Company,s management will present at the upcoming...lations in New York on May 18,2009. , The date...
...RNewswire-FirstCall/ - Oncolytics Biotech Inc. (TS...2009 Annual and Special Meeting of the Shareholder.... (MT) at the Telus World of Science, 701-11 Stree... the meeting, Dr. Brad Thompson, President and CEO...veloping REOLYSIN(R) as a potential cancer therape...
Other Biology Technology:Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 2Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 3Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 4Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 5China-Biotics, Inc. to Present at CCG Investor Relations' China Rising Conference 2China-Biotics, Inc. to Present at CCG Investor Relations' China Rising Conference 3Oncolytics Biotech(R) Inc. Announces Details of 2009 Annual Shareholder Meeting 2
(Date:11/23/2009)... biomedical engineer and cardiologist Tzung "John"...ans distinguish cardiac emergencies requiring imme...h drugs and lifestyle change. , Angiograms, imag...eding the heart, offer an inside view of the inter...n revealing deposits of a dangerous fatty substanc...
(Date:11/23/2009)...edical Sciences (NIGMS), part of the National Inst... for grants in scientific areas it identified as "...ant program to stimulate biomedical research and t...covery and Reinvestment Act (Recovery Act). , "T...significant impact on a field of biomedical scienc...
(Date:11/23/2009)...tor of the Interuniversity Professorship in Law an...niversity of the Basque Country. The Professorship...experts such as researchers in the fields of molec...ics. , The Interuniversity Professorship in Law ...o and the Basque Country was created in 1993. The ...
Breaking Biology News(10 mins):Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3Research and legislation should go hand in hand, as much as possible 2For Chest Pain in the ER CT Angiography May Be Best 61756 1Artemisinin Resistance Threatens Efforts to Control Malaria 61752 1Artemisinin Resistance Threatens Efforts to Control Malaria 61752 2Artemisinin Resistance Threatens Efforts to Control Malaria 61752 3Artemisinin Resistance Threatens Efforts to Control Malaria 61752 4U S Government Acts to Ameliorate Guatemala Malnutrition Crisis 61748 1U S Government Acts to Ameliorate Guatemala Malnutrition Crisis 61748 2
...nal water sports could all be adversely affected i...coming years prove true, according to research pub...ls . , Scientists from Biotechnology and Biologic...Wyke Research have found for the first time that t...on the amount of phosphorus lost from the soil int...
...Envisat and the Italian Space Agency,s COSMO-SkyMe... Earth during and after the 6.3 earthquake that sh... on 6 April 2009. , Scientists from Italy,s Istit...ente (IREA-CNR) and the Istituto Nazionale di Geof... Aperture Radar (SAR) data from these satellites t...
...director of the Frances and Joseph Weinberg Unit f...ciences at Thomas Jefferson University was recentl...dation grant to identify why drug therapies that s...S) mouse models have proven unsuccessful in human ...eam will closely examine critical aspects of drug ...
Other Biology News:Changing climate will lead to devastating loss of phosphorus from soil 2Satellites show how Earth moved during Italy quake 2Jefferson researcher awarded Landenberger Foundation grant for ALS research 2
...ue Arrays are intended for laboratory research use...al buffered formalin and embedded in paraffin. Ti... certified pathologists. Tissue cores were remove...new recipient paraffin block, in an array pattern,...
...ue Arrays are intended for laboratory research use...al buffered formalin and embedded in paraffin. Ti... certified pathologists. Tissue cores were remove...new recipient paraffin block, in an array pattern,...
...n rat tissue extracts (liver, kidney, spleen, and ... was also tested with microsomal fractions prepare...simple and reliable method for measuring NDPase ac...ction of the inorganic phosphate released from NDP...
CNS Side Effect Profile (CNS SEP) from Novascreen-a Caliper Life Sciences Company
Biology Products: